Product Images Ursodiol
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 3 images provide visual information about the product associated with Ursodiol NDC 0591-3005 by Actavis Pharma, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
ursodiol tablets 01
ursodiol tablets 02
NDC 0591-2998-01 is a prescription drug called Ursodiol, which is available in tablet form. The tablets are manufactured and distributed by Contabiaboratories and Actavis. Each tablet contains 250mg of Ursodiol, and the recommended adult dosage is 13-15 mg per kilogram per day in two to four divided doses with food. This drug should only be dispensed in a tight container and kept out of reach of children. For more information, please refer to the package insert. Store at a temperature between 20°C to 25°C (68°F to 77°F).*
ursodiol tablets 03
This is a medication description for Ursodiol tablets, USP, which are used for the treatment of Primary Biliary Cirrhosis. The tablets are scored and come in a container with 100 tablets. The recommended dosage is 13-15 mg/kg/day in two to four divided doses with food. The tablets should be stored at 20°C to 25°C (68°F to 77°F) in a tight container. The manufacturer is Confab Laboratories in St-Hubert (Québec) CANADA, and it is distributed by Actavis Pharma, Inc in Parsippany, USA. The text also includes information about dispensing the tablets and keeping them out of reach of children.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.